Europe Kidney Transplant Market Size (2023 to 2028)
The kidney transplant market size in Europe is anticipated to be worth USD 2.13 billion by 2028 from USD 1.88 billion in 2023, growing at a CAGR of 2.59% from 2023 to 2028.
The growing patient population suffering from end-stage renal diseases across Europe is one of the major factors driving the growth of the European kidney transplant market. With approximately 100 million people suffering from chronic kidney disease, there is a growing need for effective treatments. End-stage renal disease, characterized by a significant loss of kidney function, poses serious health complications. Kidneys play a vital role in filtering waste and excess fluids from the blood and their malfunctioning can lead to severe complications. In this context, kidney transplantation emerges as a highly effective treatment option for end-stage renal failure, contributing to the growth rate of the European kidney transplant market.
The growing aging population across Europe further propels the growth of the European kidney transplant market. As individuals age, they become more susceptible to kidney disorders, often influenced by factors such as rising diabetes rates, smoking habits, unhealthy lifestyles and the potential side effects of certain medications. Consequently, a growing number of older individuals require kidney transplantation procedures to restore their health and improve their life expectancy and overall quality of life.
The growing number of technological improvements in advanced transplantation procedures fuels the growth rate of the European kidney transplant market. Researchers and healthcare providers are actively engaged in advancing therapies and treatments for kidney issues, aiming to enhance the success rates of transplantation procedures. Manufacturers in the region are equally committed to developing cutting-edge medical devices and equipment that facilitate seamless kidney transplant procedures. They integrate sophisticated technologies such as artificial intelligence, sensors, and robotics into software and medical devices utilized during these procedures. Moreover, the constant progress in research and development, the increasing approval of innovative products, the support provided by governments and favorable reimbursement policies further contribute to the regional market growth.
The high cost associated with kidney transplant procedures is one of the key factors hampering the growth of the European kidney transplant market. Factors such as the scarcity of kidney donors, potential complications arising after transplantation, shortage of skilled healthcare professionals and stringent government regulations further impede the market growth in Europe. The considerable expenses incurred for medical equipment utilized in kidney transplant procedures, limited awareness regarding treatment options and inadequate investment in infrastructure facilities further limit the growth rate of the European market.
This research report on the Europe kidney transplant market has been segmented and sub-segmented into the following categories.
By Transplant:
By Age Group:
By End User:
By Country:
The European region accounted for a prominent share of the global market in 2022 and is anticipated to hold a substantial share of the worldwide market during the forecast period.
The UK is a promising regional market for kidney transplants and is anticipated to hold the leading share of the European market during the forecast period owing to the growing number of advancements in the healthcare sector, rising healthcare expenditure by the population and the growing number of initiatives by the UK government aimed at streamlining the kidney transplant procedure and facilitating organ donation. The strong presence of medical equipment and software manufacturing facilities for transplant procedures in the UK and the establishment of specialty hospitals dedicated to kidney transplant procedures further fuel the UK market growth.
Germany is another notable regional market for kidney transplants in Europe and Germany is renowned for its pool of skilled professionals in kidney transplantation. The presence of numerous clinical trial centers has contributed to the success rate of kidney transplant procedures the German market growth.
KEY MARKET PLAYERS:
Novartis AG, Roche Holding AG, Sanofi SA, Pfizer Inc., Bristol-Myers Squibb Company, AbbVie Inc., Astellas Pharma Inc., GlaxoSmithKline plc, Johnson & Johnson and Merck & Co., Inc. are some of the major companies in the Europe kidney transplant market.
Frequently Asked Questions
Several factors contribute to the growth of the Europe kidney transplant market, including increasing prevalence of end-stage renal diseases, advancements in surgical techniques, better organ procurement and preservation methods, and a rising number of organ donors.
Countries such as Germany, France, Spain, Italy, and the United Kingdom have a significant presence in the Europe kidney transplant market, with well-established transplant centers and advanced healthcare infrastructure.
Some of the significant challenges include a shortage of organ donors, long waiting lists for transplantation, immunological barriers, high costs associated with the procedure, and the need for lifelong immunosuppression.
Some notable trends include an increasing focus on living donor transplantation, personalized medicine approaches for better patient outcomes, telemedicine and remote monitoring for post-transplant care, and research in xenotransplantation and regenerative medicine.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region